Your shopping cart is currently empty

Anticanceragent 207 (compound 10b) is an effective anticancer agent. It binds to NRAS rG4 with a KD value of 2.31 µM. It exhibits cytotoxicity and reduces NRAS protein expression, demonstrating antitumor activity.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Anticanceragent 207 (compound 10b) is an effective anticancer agent. It binds to NRAS rG4 with a KD value of 2.31 µM. It exhibits cytotoxicity and reduces NRAS protein expression, demonstrating antitumor activity. |
| Targets&IC50 | NRAS rG4:2.31 μM (kd) |
| In vitro | Anticancer agent 207 exhibits cytotoxicity against NRAS-mutant SK-MEL-2 melanoma cells with an IC₅₀ value of 2.0 µM over 48 hours. Additionally, this agent reduces NRAS protein expression at concentrations of 0, 0.5, and 1.0 µM over 72 hours. Furthermore, Anticancer agent 207 inhibits colony formation of SK-MEL-2 cells at 0, 0.13, and 0.25 µM over a period of 10 days. |
| In vivo | The compound Anticancer agent 207, administered at a dose of 1 mg/kg intraperitoneally on a daily basis for 21 days, is capable of reducing tumor size and weight in mice. |
| Formula | C29H39FN4O2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.